Literature DB >> 1742743

Interstitial hypertension in superficial metastatic melanomas in humans.

Y Boucher1, J M Kirkwood, D Opacic, M Desantis, R K Jain.   

Abstract

Since 1950, several investigators have demonstrated that interstitial hypertension is a pathophysiological characteristic of experimental solid tumors. To date, interstitial fluid pressure (IFP) has not been measured in human tumors in situ. In this study we measured with the wick-in-needle technique the interstitial fluid pressure in superficial melanoma metastases (n = 12) in patients (n = 10) before and during systemic therapy. In the majority of tumors the pressure was found to be almost uniform, while in others it varied severalfold. The large variations in IFP in some tumors may be due to technical or biological factors. With the data obtained before and during therapy grouped, the mean IFP in melanoma lesions varied between 2 and 41 mm Hg with an overall mean of 14.3 +/- 12.5 (SD). IFP was found to be significantly higher (P less than 0.01) in large (22.8 +/- 13 mm Hg; n = 6) than in small (5.8 +/- 2mm Hg; n = 6) lesions. This study demonstrates that IFP can be measured in human tumors using the wick-in-needle technique and that the pressure in some of the large melanomas exceeds the values measured to date in rodent tumors or human tumor xenografts. The latter result suggests that caution must be exercised in extrapolating values of pathophysiological parameters from transplanted tumors to human tumors.

Entities:  

Mesh:

Year:  1991        PMID: 1742743

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  73 in total

Review 1.  Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Authors:  Shom Goel; Andus Hon-Kit Wong; Rakesh K Jain
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

2.  Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.

Authors:  Ingrid Leguerney; Nathalie Lassau; Serge Koscielny; Mélanie Rodrigues; Christophe Massard; Valérie Rouffiac; Baya Benatsou; Jessie Thalmensi; Olivia Bawa; Paule Opolon; Pierre Peronneau; Alain Roche
Journal:  Invest New Drugs       Date:  2010-10-06       Impact factor: 3.850

3.  Sensitivity analysis of an image-based solid tumor computational model with heterogeneous vasculature and porosity.

Authors:  Gregory L Pishko; Garrett W Astary; Thomas H Mareci; Malisa Sarntinoranont
Journal:  Ann Biomed Eng       Date:  2011-07-13       Impact factor: 3.934

4.  Application of prolonged microdialysis sampling in carboplatin-treated cancer patients.

Authors:  Inge R H M Konings; Frederike K Engels; Stefan Sleijfer; Jaap Verweij; Erik A C Wiemer; Walter J Loos
Journal:  Cancer Chemother Pharmacol       Date:  2008-12-20       Impact factor: 3.333

Review 5.  Targeting angiogenesis in bladder cancer.

Authors:  Aymen A Elfiky; Jonathan E Rosenberg
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

Review 6.  Imatinib mesylate and its potential implications for gynecologic cancers.

Authors:  Holly Dushkin; Russell J Schilder
Journal:  Curr Treat Options Oncol       Date:  2005-03

Review 7.  Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.

Authors:  Jie Ma; David J Waxman
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

Review 8.  Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis.

Authors:  Gavin Thurston; Nicholas W Gale
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

Review 9.  1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors.

Authors:  R K Jain
Journal:  Ann Biomed Eng       Date:  1996 Jul-Aug       Impact factor: 3.934

10.  Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.

Authors:  Sara M Tolaney; Yves Boucher; Dan G Duda; John D Martin; Giorgio Seano; Marek Ancukiewicz; William T Barry; Shom Goel; Johanna Lahdenrata; Steven J Isakoff; Eren D Yeh; Saloni R Jain; Mehra Golshan; Jane Brock; Matija Snuderl; Eric P Winer; Ian E Krop; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.